These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12436341)

  • 1. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.
    Langham RG; Kelly DJ; Cox AJ; Thomson NM; Holthöfer H; Zaoui P; Pinel N; Cordonnier DJ; Gilbert RE
    Diabetologia; 2002 Nov; 45(11):1572-6. PubMed ID: 12436341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
    Kelly DJ; Aaltonen P; Cox AJ; Rumble JR; Langham R; Panagiotopoulos S; Jerums G; Holthöfer H; Gilbert RE
    Nephrol Dial Transplant; 2002 Jul; 17(7):1327-32. PubMed ID: 12105259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
    Langham RG; Kelly DJ; Gow RM; Zhang Y; Cordonnier DJ; Pinel N; Zaoui P; Gilbert RE
    Diabetes Care; 2006 Dec; 29(12):2670-5. PubMed ID: 17130203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nephrin in renal disease including diabetic nephropathy.
    Cooper ME; Mundel P; Boner G
    Semin Nephrol; 2002 Sep; 22(5):393-8. PubMed ID: 12224046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
    Sebeková K; Lill M; Boor P; Heidland A; Amann K
    Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.
    Benigni A; Gagliardini E; Tomasoni S; Abbate M; Ruggenenti P; Kalluri R; Remuzzi G
    Kidney Int; 2004 Jun; 65(6):2193-200. PubMed ID: 15149332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
    Sharma R; Sharma M; Reddy S; Savin VJ; Nagaria AM; Wiegmann TB
    Front Biosci; 2006 Jan; 11():968-76. PubMed ID: 16146787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human nephrin mRNA in diabetic nephropathy.
    Toyoda M; Suzuki D; Umezono T; Uehara G; Maruyama M; Honma M; Sakai T; Sakai H
    Nephrol Dial Transplant; 2004 Feb; 19(2):380-5. PubMed ID: 14736962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.
    Teng B; Schroder P; Müller-Deile J; Schenk H; Staggs L; Tossidou I; Dikic I; Haller H; Schiffer M
    Diabetes; 2016 Dec; 65(12):3667-3679. PubMed ID: 27531950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
    Wolf G; Chen S; Ziyadeh FN
    Diabetes; 2005 Jun; 54(6):1626-34. PubMed ID: 15919782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
    J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
    Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
    Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
    Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
    Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
    Davis BJ; Forbes JM; Thomas MC; Jerums G; Burns WC; Kawachi H; Allen TJ; Cooper ME
    Diabetologia; 2004 Jan; 47(1):89-97. PubMed ID: 14647892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.
    Davis BJ; Johnston CI; Burrell LM; Burns WC; Kubota E; Cao Z; Cooper ME; Allen TJ
    Diabetologia; 2003 Jul; 46(7):961-71. PubMed ID: 12838387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
    Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
    Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.